Lung Non Small Cell - ORCHARD

ASTRA ZENECA D618C00001 “ORCHARD”

Objective

A Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progressed on First Line Osimertinib Therapy

Principal Investigator(s)

Andrew Horodner, MD

Ronald Natale, MD

Clinical Trial Categories

• Cedars-Sinai Clinical Trials